Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir

In 2019, EMA licensed intravenous (IV) zanamivir for severe influenza virus infection in children over 6 months as well as adults. Prior to that, it was possible via a compassionate use program. We present successful compassionate use of IV zanamivir in a 14-year-old female with severe influenza A(H...

Descripción completa

Detalles Bibliográficos
Autores principales: Alchikh, Maren, Obermeier, Patrick E., Schweiger, Brunhilde, Rath, Barbara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865252/
https://www.ncbi.nlm.nih.gov/pubmed/36678583
http://dx.doi.org/10.3390/ph16010085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865252/
https://www.ncbi.nlm.nih.gov/pubmed/36678583
http://dx.doi.org/10.3390/ph16010085

Ejemplares similares